Chemomab Therapeutics Ltd... (CMMB)
Chemomab Therapeutics Statistics
Share Statistics
Chemomab Therapeutics has 943.14K shares outstanding. The number of shares has increased by 32.62% in one year.
| 943.14K |
| 32.62% |
| 0% |
| 0.04% |
| n/a |
| 4,196 |
| 3.21% |
Short Selling Information
The latest short interest is 77.11K, so 0.41% of the outstanding shares have been sold short.
| 77.11K |
| 0.41% |
| 0.41% |
| 1 |
Valuation Ratios
The PE ratio is -105.34 and the forward PE ratio is -3.64. Chemomab Therapeutics's PEG ratio is 1.06.
| -105.34 |
| -3.64 |
| 0 |
| 0 |
| 0.11 |
| -0.1 |
| 1.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Chemomab Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.02.
| 4.98 |
| 4.98 |
| 0.02 |
| -22.08 |
| -0.02 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-697.25 |
| 20 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 14.91% in the last 52 weeks. The beta is 0.62, so Chemomab Therapeutics's price volatility has been higher than the market average.
| 0.62 |
| 14.91% |
| 1.23 |
| 1.58 |
| 49.98 |
| 130,625 |
Balance Sheet
The company has 6.07M in cash and 324K in debt, giving a net cash position of 5.75M.
| 6.07M |
| 324K |
| 5.75M |
| -102.62M |
| 16.96M |
| 12.82M |
Cash Flow
In the last 12 months, operating cash flow was -15.46M and capital expenditures 0, giving a free cash flow of -15.39M.
| -15.46M |
| n/a |
| -15.39M |
| -0.95 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
CMMB does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CMMB is $8.5, which is 548.9% higher than the current price. The consensus rating is "Strong Buy".
| $8.5 |
| 548.9% |
| Strong Buy |
| 2 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Mar 17, 2021. It was a backward split with a ratio of 1:16.
| Mar 17, 2021 |
| backward |
| 1:16 |
Scores
| -10.21 |
| 2 |